| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/30/2011 | US20110160280 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 06/30/2011 | US20110160277 Modulation of 11 beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases |
| 06/30/2011 | US20110160188 Paramyxovirus family inhibitors and methods of use thereof |
| 06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160082 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
| 06/30/2011 | US20110159607 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159595 Induction of flocculation in photosynthetic organsims |
| 06/30/2011 | US20110159594 Nucleic acids, bacteria, and methods for degrading the peptidoglycan layer of a cell wall |
| 06/30/2011 | US20110159593 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island |
| 06/30/2011 | US20110159592 COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Oct4 IN COMBINATION WITH Bmi1 OR ITS UPSTREAM REGULATOR, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAME |
| 06/30/2011 | US20110159591 Genetic material and chromosomal processing and manipulation methods |
| 06/30/2011 | US20110159587 Chimeric Molecules to Modulate Gene Expression |
| 06/30/2011 | US20110159586 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 06/30/2011 | US20110159583 MN Gene and Protein |
| 06/30/2011 | US20110159557 Compositions and methods of pgl for the increased production of isoprene |
| 06/30/2011 | US20110159555 Methods, Chimeric Polypeptides, Polynucleotides and Cells for Producing Bioplastics |
| 06/30/2011 | US20110159544 Method for treating cellulosic material and CBHII/CEL6A enzymes useful therein |
| 06/30/2011 | US20110159542 Immunosuppressive polypeptides and nucleic acids |
| 06/30/2011 | US20110159541 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159529 Fusion protein having luminescence activity |
| 06/30/2011 | US20110159526 Methods for prdicting pregnancy outcome in a subject by hcg assay |
| 06/30/2011 | US20110159514 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159491 Method for detecting cytosine methylation in DNA samples |
| 06/30/2011 | US20110159486 Cell cycle switch 52(ccs52) and methods for increasing yield |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159036 MVA expressing modified HIV envelope, GAG, and POL genes |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159032 Modified vaccinia virus ankara for the vaccination of neonates |
| 06/30/2011 | US20110159031 Vaccine to Influenza A Virus |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine |
| 06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
| 06/30/2011 | US20110159020 Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159008 Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158988 Antibodies against extracellular domains 2 and 3 or her2 |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110158974 Heterodimeric Meganucleases and Use Thereof |
| 06/30/2011 | US20110158970 Fungi transformant for melanin production and uses thereof |
| 06/30/2011 | US20110158957 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| 06/30/2011 | US20110158954 Method for producing gamma delta t cell population |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | US20110158908 Cyclosporin a-binding protein |
| 06/30/2011 | US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 06/30/2011 | US20110155605 Apo-2 ligand |
| 06/30/2011 | US20110155587 System and method for detecting a substance in liquid |
| 06/30/2011 | US20110154581 Polyol oxidases |
| 06/30/2011 | CA2785480A1 Compositions and methods of pgl for the increased production of isoprene |
| 06/30/2011 | CA2785451A1 Molecule for treating an inflammatory disorder |
| 06/30/2011 | CA2785414A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | CA2785276A1 Xylose isomerase and use thereof |
| 06/30/2011 | CA2785266A1 Orthogonal q-ribosomes |
| 06/30/2011 | CA2785225A1 Plants tolerant to hppd inhibitor herbicides |
| 06/30/2011 | CA2785220A1 Plants tolerant to hppd inhibitor herbicides. |
| 06/30/2011 | CA2785211A1 Plants tolerant to hppd inhibitor herbicides. |
| 06/30/2011 | CA2785208A1 Plants tolerant to hppd inhibitor herbicides |
| 06/30/2011 | CA2785126A1 Plants tolerant to hppd inhibitor herbicides |
| 06/30/2011 | CA2784936A1 Herbicide tolerant plants |
| 06/30/2011 | CA2784711A1 Plant membrane bound o-acyl transferase (mboat) family protein sequences and their uses for altering fatty acid compositions |
| 06/30/2011 | CA2784550A1 Method of transforming cells |
| 06/30/2011 | CA2784547A1 Influenza targets |
| 06/30/2011 | CA2784344A1 Tsg primer target detection |
| 06/30/2011 | CA2784243A1 Promoter sequences |
| 06/30/2011 | CA2783551A1 Improved techniques for transfecting protoplasts |
| 06/30/2011 | CA2783543A1 Diacylglycerol acyltransferase genes and use thereof |
| 06/30/2011 | CA2782375A1 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 06/30/2011 | CA2782373A1 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 06/30/2011 | CA2782300A1 Gene dro1 controlling deep-rooted characteristics of plant and utilization of same |
| 06/29/2011 | EP2339350A1 Arrays |
| 06/29/2011 | EP2339347A1 Method of identifying transmembrane protein-interacting compounds |
| 06/29/2011 | EP2339326A1 Automatic threshold setting and baseline determination for real-time PCR |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339034A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/29/2011 | EP2339033A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/29/2011 | EP2339031A1 Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field |
| 06/29/2011 | EP2339030A1 Screening method for liver x receptor agonists and application thereof |
| 06/29/2011 | EP2339029A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 06/29/2011 | EP2339028A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 06/29/2011 | EP2339025A1 Methods and compositions for determining methylation profiles |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2339017A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339016A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339015A1 Methods for altering protein production rates |
| 06/29/2011 | EP2339013A1 Methods for producing modified glycoproteins |
| 06/29/2011 | EP2339011A1 West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 06/29/2011 | EP2339010A2 Lentiviral vector particles resistant to complement inactivation |
| 06/29/2011 | EP2339009A1 Cold inducible promoter sequences |